In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

VCs buy commercial lab business of Genoptix from Novartis

Executive Summary

Ampersand Capital and 1315 Capital have acquired Genoptix Inc. (clinical oncology diagnostics and informatics services) from Novartis AG for an undisclosed sum. The acquisition primarily includes Genoptix's commercial laboratory business; the firm's biopharma business was retained by Novartis and will operate as a new legal entity named Navigate Biopharma Services. Novartis originally purchased Genoptix for $440mm in 2011.
Deal Industry
  • In Vitro Diagnostics
  • Laboratory Testing Services
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
Deal Status
  • Final
Deal Type
  • Acquisition
    • Buy-out
    • Full Acquisition

Related Companies